Low-dose IL-2 expands CD4⁺ regulatory T cells with a suppressive function in vitro via the STAT5-dependent pathway in patients with chronic kidney diseases

References

• Kurts C, Panzer U, Anders HJ, et al. The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol. 2013;13:738–753.
   PubMed Web of Science ®Google Scholar
• Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013;9:255–265.
   PubMed Web of Science ®Google Scholar
• Hu M, Wang YM, Wang Y, et al. Regulatory T cells in kidney disease and transplantation. Kidney Int. 2016;90:502–514.
   PubMedGoogle Scholar
• Safinia N, Scotta C, Vaikunthanathan T, et al. Regulatory T cells: serious contenders in the promise for immunological tolerance in transplantation. Front Immunol. 2015;6:438.
   PubMed Web of Science ®Google Scholar
• Hendrikx TK, van Gurp EA, Mol WM, et al. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells. Nephrol Dial Transpl. 2009;24:1969–1978.
   PubMed Web of Science ®Google Scholar
• Yoshimura J, Fukami K, Koike v, et al. Interstitial Foxp3-positive T cells may predict renal survival in patients with myeroperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Clin Exp Pharmacol Physiol. 2010;37:879–883.
   PubMed Web of Science ®Google Scholar
• Paust HJ, Ostmann A, Erhardt A, et al. Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis. Kidney Int. 2011;80:154–164.
   PubMed Web of Science ®Google Scholar
• Mansouri L, Nopp A, Jacobson SH, et al. Hemodialysis patients display a declined proportion of Th2 and regulatory T cells in parallel with a high interferon-γ profile. Nephron. 2017;136:254–260.
   PubMed Web of Science ®Google Scholar
• Thornton AM, Donovan EE, Piccirillo CA, et al. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol. 2014;172:6519–6523.
   Google Scholar
• Koreth J, Matsuoka K, Kim HT, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365:2055–2066.
   PubMed Web of Science ®Google Scholar
• Saadoun D, Rosenzwajg M, Joly F, et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med. 2011;365:2067–2077.
   PubMed Web of Science ®Google Scholar
• Rosenzwajg M, Churlaud G, Mallone R, et al. Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients. J Autoimmun. 2015;58:48–58.
   PubMed Web of Science ®Google Scholar
• Von SC, Siegert E, Abdirama D, et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis. 2016;75:1407–1415.
   PubMed Web of Science ®Google Scholar
• He J, Zhang X, Wei Y, et al. Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus. Nat Med. 2016;22:991–993.
   PubMed Web of Science ®Google Scholar
• Hippen KL, Merkel SC, Schirm DK, et al. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Transl Med. 2011;3:83ra41.
   PubMed Web of Science ®Google Scholar
• Passerini L, Rossi ME, Sartirana C, et al. CD4+ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer. Sci Transl Med. 2012;5:215ra174.
   Web of Science ®Google Scholar
• Lu L, Zhou X, Wang J, et al. Characterization of protective human CD4+CD25+ FOXP3+ regulatory T cells generated with IL-2, TGF-β and retinoic acid. PLoS One. 2010;5:e15150.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:1–150.
   Web of Science ®Google Scholar
• Bonanni A, Bertelli R, Rossi R, et al. A pilot study of IL-2 in drug-resistant idiopathic nephrotic syndrome. PLoS One. 2015;10:e0138343.
   PubMed Web of Science ®Google Scholar
• Azadegandehkordi F, Bagheri N, Shirzad H, et al. The role of Th1 and Th17 cells in glomerulonephritis. J Nephropathol. 2015;4:32–37.
   PubMedGoogle Scholar
• Chauhan SK, Saban DR, Lee HK, et al. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol. 2009;182:148–153.
   PubMed Web of Science ®Google Scholar
• Feuerer M, Hill JA, Mathis D, et al. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol. 2009;10:689–695.
   PubMed Web of Science ®Google Scholar
• Mahmud SA, Manlove LS, Farrar MA. Interleukin-2 and STAT5 in regulatory T cell development and function. JAK-STAT. 2013;2:e23154.
   PubMedGoogle Scholar
• Ghali JR, Wang YM, Holdsworth SR, et al. Regulatory T cells in immune-mediated renal disease. Nephrology. 2016;21:86–96.
   PubMed Web of Science ®Google Scholar
• Litjens NH, Boer K, Zuijderwijk JM, et al. Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs. Kidney Int. 2017;91:1203–1213.
   PubMed Web of Science ®Google Scholar
• Chen G, Dong Z, Liu H, et al. mTOR signaling regulates protective activity of transferred CD4+Foxp3+ T cells in repair of acute kidney injury. J Immunol. 2016;197:3917–3926.
   PubMed Web of Science ®Google Scholar
• Yang C, Huang XR, Fung E, et al. The regulatory T-cell transcription factor Foxp3 protects against crescentic glomerulonephritis. Sci Rep. 2017;7:1481.
   PubMed Web of Science ®Google Scholar
• Yazici MU, Orhan D, Kale G, et al. Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis. Pediatr Nephrol. 2014;9:853–862.
   Google Scholar
• Krebs CF, Steinmetz OM. CD4+ T cell fate in glomerulonephritis: a tale of Th1, Th17, and novel Treg subtypes. Mediators Inflamm. 2016;2016:1–9.
   Google Scholar
• Zwang NA, Leventhal JR. Cell therapy in kidney transplantation: focus on regulatory T cells. J Am Soc Nephrol. 2017;28:1960–1972.
   PubMed Web of Science ®Google Scholar